Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.

Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN
Biol Blood Marrow Transplant. 2012 18 (7): 1069-75

PMID: 22178694 · DOI:10.1016/j.bbmt.2011.12.518

MeSH Terms (19)

Adolescent Adult Aged CTLA-4 Antigen Female Graft vs Tumor Effect Hematologic Neoplasms Hematopoietic Stem Cell Transplantation Humans Male Middle Aged Polymorphism, Single Nucleotide Risk Factors Secondary Prevention Survival Analysis T-Lymphocytes, Cytotoxic Tissue Donors Transplantation, Homologous Treatment Outcome

Connections (3)

This publication is referenced by other Labnodes entities:

Links